# 胃癌TMEscore(源于曾东强博士) **Repository Path**: focuslyj/TMEscore ## Basic Information - **Project Name**: 胃癌TMEscore(源于曾东强博士) - **Description**: No description available - **Primary Language**: Unknown - **License**: GPL-3.0 - **Default Branch**: master - **Homepage**: None - **GVP Project**: No ## Statistics - **Stars**: 0 - **Forks**: 0 - **Created**: 2023-12-06 - **Last Updated**: 2023-12-06 ## Categories & Tags **Categories**: Uncategorized **Tags**: None ## README # TMEscore ### 1.Introduction TME infiltration patterns were determined and systematically correlated with TME cell phenotypes, genomic traits, and patient clinicopathological features to establish the [TMEscore](https://cancerimmunolres.aacrjournals.org/content/7/5/737): *Tumor Microenvironment Characterization in Gastric Cancer Identifies Prognostic and Immunotherapeutically Relevant Gene Signatures*. ![TMEscore logo](./man/TMEscore-honors.png) TMEscore is an R package to estimate tumor microenvironment score. Provides functionality to calculate Tumor microenvironment (TME) score using PCA or z-score. ### 2.Installation The package is not yet on CRAN. You can install from Github: ``` r # install.packages("devtools") if (!requireNamespace("TMEscore", quietly = TRUE)) devtools::install_github("DongqiangZeng0808/TMEscore") ``` ### 3.Usage Main documentation is on the `tmescore` function in the package: ``` r library('TMEscore') #> 载入需要的程辑包:survival #> Warning: 程辑包'survival'是用R版本4.2.1 来建造的 #> 载入需要的程辑包:survminer #> 载入需要的程辑包:ggplot2 #> 载入需要的程辑包:ggpubr #> #> 载入程辑包:'survminer' #> The following object is masked from 'package:survival': #> #> myeloma #> TMEscore v0.1.4 For help: https://github.com/DongqiangZeng0808/TMEscore #> #> If you use TMEscore in published research, please cite: #> -------------------------------- #> Tumor microenvironment evaluation promotes precise checkpoint immunotherapy of advanced gastric cancer. #> Journal for ImmunoTherapy of Cancer, 2021, 9(8), e002467 #> DOI: 10.1136/jitc-2021-002467 #> PMID: 34376552 #> -------------------------------- #> Tumor microenvironment characterization in gastric cancer identifies prognostic and imunotherapeutically relevant gene signatures. #> Cancer Immunology Research, 2019, 7(5), 737-750 #> DOI: 10.1158/2326-6066.CIR-18-0436 #> PMID: 30842092 #> -------------------------------- library("ggplot2") library("patchwork") ``` Example ``` r tmescore<-tmescore(eset = eset_stad, #expression data pdata = pdata_stad, #phenotype data method = "PCA", #default classify = T) #if true, survival data must be provided in pdata head(tmescore) #> ID subtype time status TMEscoreA TMEscoreB TMEscore #> 284 TCGA-RD-A8N2 118.00 0 -6.705998 11.66689 -18.37289 #> 95 TCGA-BR-A4IV GS 28.97 1 -6.376907 10.91756 -17.29446 #> 66 TCGA-BR-8371 GS 11.97 1 -6.258413 10.94738 -17.20580 #> 69 TCGA-BR-8380 GS NA 1 -5.213597 11.38528 -16.59887 #> 101 TCGA-BR-A4J9 GS 0.47 0 -5.463828 10.55516 -16.01899 #> 82 TCGA-BR-8592 GS 6.37 1 -5.003108 10.84967 -15.85278 #> TMEscore_binary #> 284 Low #> 95 Low #> 66 Low #> 69 Low #> 101 Low #> 82 Low ``` ``` r #remove observation with missing value tmescore<-tmescore[!is.na(tmescore$subtype),] p<-ggplot(tmescore,aes(x= subtype,y=TMEscore,fill=subtype))+ geom_boxplot(notch = F,outlier.shape = 1,outlier.size = 0.5)+ scale_fill_manual(values= c('#374E55FF', '#DF8F44FF', '#00A1D5FF', '#B24745FF')) comparision<-combn(unique(as.character(tmescore$subtype)), 2, simplify=F) p1<-p+theme_light()+ stat_compare_means(comparisons = comparision,size=2.5)+ stat_compare_means(size=2.5) # survival analysis colnames(tmescore)[which(colnames(tmescore)=="TMEscore_binary")]<-"score" fit<- survfit(Surv(time, status) ~ score, data = tmescore) p2<-ggsurvplot(fit, conf.int = FALSE, palette = c('#374E55FF', '#DF8F44FF'), risk.table = TRUE, pval = TRUE, risk.table.col = "strata") p2<-list(p2) p2 <- arrange_ggsurvplots(p2, print = FALSE, ncol = 1, nrow = 1) # print plots (p1|p2)+plot_layout(ncol = 2, widths = c(1,2)) ``` ### Citation If you use TMEscore in published research, please cite: 1. [Tumor microenvironment evaluation promotes precise checkpoint immunotherapy of advanced gastric cancer](https://jitc.bmj.com/content/9/8/e002467). *Journal for ImmunoTherapy of Cancer*, 2021, 9(8), e002467. DOI: 10.1136/jitc-2021-002467, PMID: 34376552 2. [Tumor microenvironment characterization in gastric cancer identifies prognostic and imunotherapeutically relevant gene signatures](https://cancerimmunolres.aacrjournals.org/content/7/5/737). *Cancer Immunology Research*, 2019, 7(5), 737-750. DOI: 10.1158/2326-6066.CIR-18-0436, PMID: 30842092 ### Contact E-mail any questions to or